首页> 外国专利> METHOD OF TREATING PATIENTS AFTER AGE-RELATED CATARACT PHACOEMULSIFICATION

METHOD OF TREATING PATIENTS AFTER AGE-RELATED CATARACT PHACOEMULSIFICATION

机译:年龄相关性白内障晶状体化后治疗患者的方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to ophthalmology, and aims at treating patients after phacoemulsification of age-related cataract. After phacoemulsification of age-related cataract, in addition to standard application of antibiotic solution to patient in conjunctival cavity of operated eye for 30 days 2 times day for 1 drop of combined preparation is installed, consisting of 6.0 ml of tear substitute based on 0.15 % sodium salt of hyaluronic acid, 3.0 ml of 0.1 % dexamethasone and 1.0 ml of 0.25 % Derinat.;EFFECT: use of the invention provides preventing postoperative induced damage of eye surface structures and dry eye syndrome after phacoemulsification, improved local immune status of the operated eye, reduced number of instillations and ease of use for the patient.;1 cl, 2 ex
机译:技术领域本发明涉及医学,即眼科,旨在治疗年龄相关性白内障超声乳化后的患者。在对年龄相关性白内障进行超声乳化后,除了将抗生素溶液标准施用于手术眼结膜腔内的患者30天,每天2次,每次1滴组合制剂,其中包括6.0毫升基于0.15%的眼泪替代品透明质酸钠,3.0 ml的0.1%地塞米松和1.0 ml的0.25%Derinat。效果:本发明的使用可防止超声乳化术后预防眼表结构和干眼症的术后诱发损伤,改善手术者的局部免疫状态眼,滴注次数减少,患者易于使用。; 1 cl,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号